- Home
- MNTK vs ORIC Comparison
MNTK vs ORIC Comparison
Compare MNTK & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNTK
- ORIC
- Stock Information
- Founded
- MNTK 1980
- ORIC 2014
- Country
- MNTK United States
- ORIC United States
- Employees
- MNTK N/A
- ORIC N/A
- Industry
- MNTK Natural Gas Distribution
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- MNTK Utilities
- ORIC Health Care
- Exchange
- MNTK Nasdaq
- ORIC Nasdaq
- Market Cap
- MNTK 622.2M
- ORIC 735.3M
- IPO Year
- MNTK 2021
- ORIC 2020
- Fundamental
- Price
- MNTK $4.22
- ORIC $10.84
- Analyst Decision
- MNTK Hold
- ORIC Strong Buy
- Analyst Count
- MNTK 2
- ORIC 9
- Target Price
- MNTK $6.00
- ORIC $18.75
- AVG Volume (30 Days)
- MNTK 156.6K
- ORIC 825.1K
- Earning Date
- MNTK 03-13-2025
- ORIC 03-10-2025
- Dividend Yield
- MNTK N/A
- ORIC N/A
- EPS Growth
- MNTK 42.11
- ORIC N/A
- EPS
- MNTK 0.16
- ORIC N/A
- Revenue
- MNTK $194,849,000.00
- ORIC N/A
- Revenue This Year
- MNTK $21.28
- ORIC N/A
- Revenue Next Year
- MNTK $31.59
- ORIC N/A
- P/E Ratio
- MNTK $26.27
- ORIC N/A
- Revenue Growth
- MNTK 9.63
- ORIC N/A
- 52 Week Low
- MNTK $3.38
- ORIC $6.33
- 52 Week High
- MNTK $6.88
- ORIC $16.65
- Technical
- Relative Strength Index (RSI)
- MNTK 47.56
- ORIC 52.90
- Support Level
- MNTK $4.01
- ORIC $9.92
- Resistance Level
- MNTK $4.34
- ORIC $12.00
- Average True Range (ATR)
- MNTK 0.22
- ORIC 0.90
- MACD
- MNTK -0.02
- ORIC 0.04
- Stochastic Oscillator
- MNTK 20.63
- ORIC 41.82
About MNTK Montauk Renewables Inc.
Montauk Renewables Inc is a United States-based renewable energy company. It specializes in the recovery and processing of biogas from landfills and other non-fossil fuel sources for beneficial use as a replacement for fossil fuels. The firm develops, owns, and operates RNG projects that supply renewable fuel into the transportation and electrical power sectors. Montauk operates in two segments: Renewable Natural Gas and Renewable Electricity Generation. It generates a majority of its revenue from the Renewable Natural Gas segment.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.